文献速递鼻科

光生物调节疗法治疗过敏性鼻炎的效果:一项安慰剂对照随机临床试验

Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo-Controlled Randomized Clinical Trial.
PubMed 文献 · Int Forum Allergy Rhinol · 2025-01-19

本研究为随机、安慰剂对照、双盲临床试验,纳入62例过敏性鼻炎患者,光生物调节疗法(PBMT)组33例接受鼻内6 J红光与红外光及鼻外1 J红外光治疗,对照组29例使用不发光装置,每周2次共8次、历时1个月。结果显示PBMT组鼻腔吸气峰流量显著改善(p < 0.001),鼻塞症状评估量表(p = 0.048)和鼻炎控制评估测试(p = 0.035)显著改善,但宾夕法尼亚大学嗅觉识别测试无显著变化(p = 0.251)。作者认为PBMT可能成为过敏性鼻炎患者有前景的治疗选择,为无法耐受常规药物者提供替代方案。

要点

  • PBMT组鼻腔吸气峰流量较对照组显著改善(p < 0.001)。
  • 鼻塞症状评估量表(p = 0.048)和鼻炎控制评估测试(p = 0.035)显著改善。
  • 宾夕法尼亚大学嗅觉识别测试显示嗅觉功能无显著变化(p = 0.251)。

核心结论

  • 作者认为PBMT可能成为过敏性鼻炎患者有前景的治疗选择,为无法耐受常规药物者提供替代方案,并显示其作为可行替代治疗的有效性和安全性。

研究设计与样本

  • 随机、安慰剂对照、双盲临床试验,纳入62例过敏性鼻炎患者。
  • PBMT组33例接受鼻内6 J红光与红外光及鼻外1 J红外光方案,对照组29例使用不发光装置,每周2次共8次、历时1个月。
  • 治疗前后进行鼻塞和嗅觉功能的客观、心理物理及主观评估。

主要发现

  • PBMT组鼻腔吸气峰流量显著改善(p < 0.001)。
  • 鼻塞症状评估量表显示鼻塞显著改善(p = 0.048)。
  • 鼻炎控制评估测试反映过去一周症状显著改善(p = 0.035)。
  • 宾夕法尼亚大学嗅觉识别测试显示嗅觉功能无显著变化(p = 0.251)。

临床怎么用

  • 作者认为PBMT可能作为过敏性鼻炎患者无法耐受常规药物时的替代治疗选择。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent studies have extensively explored new non-invasive and side-effect-free therapeutic strategies for the treatment of allergic rhinitis (AR). Photobiomodulation therapy (PBMT) utilizes photons from the red to infrared spectrum to modulate biological processes, exhibiting anti-inflammatory and regenerative properties. The objective of our study was to evaluate the efficacy of PBMT in patients with AR. METHODS: This study was a randomized, placebo-controlled, double-blind clinical trial involving 62 patients with AR. Participants underwent PBMT twice weekly, totaling eight sessions over the course of 1 month. The control group consisted of 29 patients who received treatment with a non-light-emitting device, while 33 patients in the laser therapy group received a protocol of 6 J of red and infrared light administered intranasally, along with 1 J of infrared light applied externally to the nose. Objective, psychophysical, and subjective assessments of nasal obstruction and olfactory function were conducted both before and after the treatment. RESULTS: PBMT contributed to significant improvements in various nasal and respiratory parameters. The peak nasal inspiratory flow demonstrated significant improvement (p < 0.001), and the Nasal Obstruction Symptom Evaluation scale indicated notable enhancement in nasal obstruction (p = 0.048). Additionally, the Rhinitis Control Assessment Test reflected significant symptom improvement over the past week (p = 0.035). However, the University of Pennsylvania Smell Identification Test showed no significant change in olfactory function (p = 0.251). CONCLUSION: Our data suggest that PBMT may serve as a promising therapeutic option for individuals with AR, providing an alternative for those who are unable to tolerate conventional medications. Furthermore, it demonstrates efficacy and safety as a viable treatment alternative.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Oliveira PC, Correia LO, Lopes NMD, et al. Efficacy of Using Photobiomodulation Therapy in Allergic Rhinitis: A Placebo-Controlled Randomized Clinical Trial. Int Forum Allergy Rhinol. 2025. PMID: 39828891. doi:10.1002/alr.23532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。